Table 3.
Operative outcomes
| n (%) | All patients (N = 62) | m-VA (n = 26) | c-VA (n = 36) | P |
|---|---|---|---|---|
| MAE (at 30 d) | 5 (8.1%) | 3 (11.5%) | 2 (5.6%) | .397 |
| Death | – | – | – | – |
| MI | – | – | – | – |
| Stroke | 1 (1.6%) | 1 (3.8%) | – | .239 |
| Acute kidney injury | 1 (1.6%) | – | 1 (2.8%) | .395 |
| Respiratory failure | 3 (4.8%) | 2 (7.7%) | 1 (2.8%) | .377 |
| Major bleeding | – | – | – | – |
| New PPM | – | – | – | – |
| Cardiac reintervention (any) | – | – | – | – |
| Residual MR >1+ | – | – | – | – |
| Recurrent VA | 1 (1.6%) | – | 1 (2.8%) | .395 |
| MAE (at 1 y) | All (N = 54) | m-VA (n = 21) | c-VA (n = 33) | |
| Recurrent MR >1+ | – | – | – | – |
| Cardiac-related hospital admission | – | – | – | – |
| Cardiac reintervention (any) | – | – | – | – |
| Recurrent VA | 13 (24.1%) | 1 (4.8%) | 12 (36.4%) | .009 |
m-VA, Minor ventricular arrhythmia; c-VA, complex ventricular arrhythmia; MAE, major adverse events; MI, myocardial infarction; PPM, permanent pacemaker; MR, mitral regurgitation; VA, ventricular arrhythmia.